MEDIROM Stock Analysis

MRM -  USA Stock  

USD 9.58  0.01  0.10%

The new indifference towards the small price fluctuations of MEDIROM Healthcare Technologies may encourage stakeholders to take a closer look at the firm as it is trading at a share price of 9.58 on 2,910 in trading volume. The company directors and management did not add any value to MEDIROM Healthcare investors in May. However, most investors can still diversify their portfolios with MEDIROM Healthcare Technologies to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.42. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the MEDIROM Healthcare partners.
Additionally, see Stocks Correlation.

Search Stock Analysis 

The MEDIROM Healthcare stock analysis report makes it easy to digest most publicly released information about MEDIROM Healthcare and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. MEDIROM stock analysis module also helps to analyze the MEDIROM Healthcare price relationship with some important fundamental indicators such as market cap and management efficiency.

MEDIROM Stock Analysis Notes

About 33.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. MEDIROM Healthcare Technologies Inc. provides holistic health services in Japan. MEDIROM Healthcare Technologies Inc. was founded in 2000 and is headquartered in Tokyo, Japan. MEDIROM Healthcare operates under Personal Services classification in the United States and is traded on NASDAQ Exchange. It employs 180 people. To find out more about MEDIROM Healthcare Technologies contact Jacques Blanchard at 81 3 6721 7364 or learn more at

MEDIROM Healthcare Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. MEDIROM Healthcare's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding MEDIROM Healthcare Technologies or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
MEDIROM Healthcare has very high historical volatility over the last 90 days
MEDIROM Healthcare has high likelihood to experience some financial distress in the next 2 years
The company has 2.39 B in debt. MEDIROM Healthcare has a current ratio of 0.36, suggesting that it has not enough short term capital to pay financial commitments when the payables are due.
The entity reported the last year's revenue of 3.23 B. Reported Net Loss for the year was (479.68 M) with profit before taxes, overhead, and interest of 950.76 M.
MEDIROM Healthcare Technologies has about 257.58 M in cash with (548.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 64.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
MEDIROM Healthcare has a poor financial position based on the latest SEC disclosures
Roughly 33.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MEDIROM Healthcare Technologies Inc - ADR gains 0.9480 percent for June 04 -

MEDIROM Healthcare SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. MEDIROM Healthcare prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that MEDIROM Healthcare investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial MEDIROM Healthcare specific information freely available to individual and institutional investors to make a timely investment decision.

MEDIROM Healthcare Thematic Classifications

In addition to having MEDIROM Healthcare stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Personal Services IdeaPersonal Services
USA Equities from Personal Services industry as classified by Fama & French

MEDIROM Market Capitalization

The company currently falls under 'Micro-Cap' category with total capitalization of 55.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MEDIROM Healthcare's market, we take the total number of its shares issued and multiply it by MEDIROM Healthcare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

MEDIROM Profitablity

MEDIROM Healthcare's profitability indicators refer to fundamental financial ratios that showcase MEDIROM Healthcare's ability to generate income relative to its revenue or operating costs. If, let's say, MEDIROM Healthcare is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, MEDIROM Healthcare's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of MEDIROM Healthcare's profitability requires more research than a typical breakdown of MEDIROM Healthcare's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of (14.84) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (13.65) %, which entails that for every $100 of revenue, it lost -0.14.
Last ReportedProjected for 2021
Return on Average Assets(0.10) (0.11) 
Return on Average Equity(0.99) (1.01) 
Return on Invested Capital(0.15) (0.15) 
Return on Sales(0.18) (0.19) 

Management Efficiency

The entity has Return on Asset of (7.64) % which means that on every $100 spent on asset, it lost $7.64. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (98.81) %, meaning that it generated no profit with money invested by stockholders. MEDIROM Healthcare management efficiency ratios could be used to measure how well medirom healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return on Average Assets is estimated to pull down to -0.11. The value of Return on Average Equity is estimated to pull down to -1.01. MEDIROM Healthcare Average Assets are relatively stable at the moment as compared to the past year. The company's current value of Average Assets is estimated at 5.61 Billion. Tangible Asset Value is expected to hike to about 5.7 B this year, although the value of Goodwill and Intangible Assets will most likely fall to nearly 235.8 M.
Last ReportedProjected for 2021
Book Value per Share 122.06  112.52 
Enterprise Value over EBIT(12.60) (13.59) 
Enterprise Value over EBITDA(14.49) (15.63) 
Price to Book Value 12.94  12.86 
Tangible Assets Book Value per Share1.4 K1.4 K
Enterprise Value77.1 M76.7 M
Tangible Asset Value5.5 B5.7 B

Technical Drivers

As of the 17th of June 2021, MEDIROM Healthcare secures the risk adjusted performance of 0.0141, and Mean Deviation of 3.77. Compared to fundamental indicators, the technical analysis model lets you check possible technical drivers of MEDIROM Healthcare, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for MEDIROM Healthcare, which can be compared to its peers in the industry. Please verify MEDIROM Healthcare variance, as well as the relationship between the value at risk and skewness to decide if MEDIROM Healthcare Technologies is priced fairly, providing market reflects its recent price of 9.58 per share. Given that MEDIROM Healthcare has jensen alpha of 0.0576, we recommend you to check MEDIROM Healthcare's last-minute market performance to make sure the company can sustain itself in the future.

MEDIROM Healthcare Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of MEDIROM Healthcare more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

MEDIROM Healthcare Predictive Daily Indicators

MEDIROM Healthcare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MEDIROM Healthcare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

MEDIROM Healthcare Forecast Models

MEDIROM Healthcare time-series forecasting models is one of many MEDIROM Healthcare's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MEDIROM Healthcare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About MEDIROM Healthcare Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how MEDIROM Healthcare stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MEDIROM shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as MEDIROM Healthcare. By using and applying MEDIROM Stock analysis, traders can create a robust methodology for identifying MEDIROM entry and exit points for their positions.
Last ReportedProjected for 2021
EBITDA Margin(0.17) (0.17) 
Gross Margin 0.13  0.16 
Profit Margin(0.16) (0.16) 
MEDIROM Healthcare Technologies Inc. provides holistic health services in Japan. MEDIROM Healthcare Technologies Inc. was founded in 2000 and is headquartered in Tokyo, Japan. MEDIROM Healthcare operates under Personal Services classification in the United States and is traded on NASDAQ Exchange. It employs 180 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding MEDIROM Healthcare to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Competition Analyzer Now


Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module
Additionally, see Stocks Correlation. Note that the MEDIROM Healthcare information on this page should be used as a complementary analysis to other MEDIROM Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for MEDIROM Healthcare Stock analysis

When running MEDIROM Healthcare stock analysis, check to measure MEDIROM Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIROM Healthcare is operating at the current time. Most of MEDIROM Healthcare's stock examination focuses on studying past and present price action to predict the probability of MEDIROM Healthcare's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move MEDIROM Healthcare's price. Additionally, you may evaluate how the addition of MEDIROM Healthcare to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively-traded Exchange Traded Funds (ETF) from around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
The market value of MEDIROM Healthcare is measured differently than its book value, which is the value of MEDIROM that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIROM Healthcare stock's value that differs from its market value or its book value, called intrinsic value, which is MEDIROM Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIROM Healthcare's market value can be influenced by many factors that don't directly affect MEDIROM Healthcare underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIROM Healthcare's stock value and its price as these two are different measures arrived at by different means. Investors typically determine MEDIROM Healthcare value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIROM Healthcare's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.